Noble Capital Starts MAIA Biotechnology (MAIA) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts MAIA Hot Sheet
Price: $1.10 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 16
Join SI Premium – FREE
Noble Capital analyst Robert LeBoyer initiates coverage on MAIA Biotechnology (NYSE: MAIA) with a Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on MAIA Biotechnology click here. For more ratings news on MAIA Biotechnology click here.
Shares of MAIA Biotechnology closed at $4.53 yesterday.
You May Also Be Interested In
- BTIG Starts SharkNinja (SN) at Buy
- Nomura/Instinet Starts Page Industries Ltd. (PAG:IN) at Buy
- Northland Starts Aeluma (ALMU) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
